A mistrial in the most recent Vioxx case. Some say this is not a good sign for Merck:
Legal analysts had predicted that the case would be decided in Merck’s favor because the patient in question had taken Vioxx for barely a month. The mistrial points to some jurors’ willingness to trace serious health problems to even short-term use of the drug, raising concerns for Merck as it faces thousands of similar lawsuits.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
